Your SlideShare is downloading. ×
0
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Intuitive Surgical Earnings: 3 Things to Watch
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Intuitive Surgical Earnings: 3 Things to Watch

1,790

Published on

Here's what this shareholder of Intuitive Surgical shares will be watching when the company reports earnings this week.

Here's what this shareholder of Intuitive Surgical shares will be watching when the company reports earnings this week.

Published in: Economy & Finance
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total Views
1,790
On Slideshare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
3
Comments
0
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Intuitive Surgical Earnings: 3 Things to Watch
  • 2. Short-Term Investors
  • 3. Wall Street Expectations Revenue Q2: $502 million Full Year: $2.04 billion Earnings per Share Q2: $2.83 Full Year: $11.58 Short-Term Investors
  • 4. •Because of uncertainty surrounding system sales in the United States, Intuitive Surgical hasn’t been offering guidance. •That being said, how the company performs against expectations will go a long way in determining the stock’s fate over the short-term. •It will be interesting to see if management feels comfortable reinstating guidance moving forward. Short-Term Investors
  • 5. Medium-Term Investors
  • 6. daVinci System Sales Many investors will be watching to see if U.S. hospitals will start loosening the purse strings to buy more daVinci robots. Medium-Term Investors
  • 7. •For years, the company showed double digit growth in system sales for the daVinci in the United States. That growth actually went negative earlier this year. •Investors shouldn’t read too much into the system sales themselves, as uncertainty surrounding the Affordable Care Act is still lingering, and hospitals are likely wanting to see if the new daVinci Xi is worth the money. •Instead, focus on management comments regarding reception to the Xi. Medium-Term Investors
  • 8. Long-Term Investors
  • 9. More Surgical Diversity In order to be continually relevant for decades to come, the daVinci needs to help doctors perform surgery in ever-more procedures. Long-Term Investors
  • 10. •Historically, the company’s machine has been most oft- used to perform hysterectomies and prostatectomies. •Last year, however, leading voices in the women’s health industry questioned the efficacy of using the daVinci to perform hysterectomies. •Some believe the new Xi will help diversify the types of procedures the daVinci can be used for. Listen in for specific results in “general surgery”, and comments by management. Long-Term Investors

×